Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability ...
In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...
Knight Therapeutics Inc. ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PMtm, an extended-release formulation of ...
Incremental Payments Received based on Executed Global Licensing Agreements that could provide up to $292 million in income Key Financial and Operational Highlights: Impressive Revenue Growth: ABVC ...